Richard Drew / AP

The Dow Jones closed on Tuesday at the lowest level of 2017

Investors are starting to lose confidence that the top priorities of the Trump Administration are sure bets to boost corporate profits. With the Obamacare repeal taking center stage in Washington, chances of swift action on infrastructure spending and corporate tax reform have come down, along with some of the more optimistic valuations of America's biggest companies.

UnitedHealth profits from shunning Obamacare

Their decision to longer offer coverage through Obamacare exchanges paid off big in the fourth quarter of 2016, with company saying Tuesday that its profits rose more than 50% from a year ago, when it recognized large losses resulting from participation in state-run exchanges.

In a call with analysts, CEO Stephen Hemsley said that he had been in touch with "high levels" of the Trump transition team, but didn't share the details of those discussions other than to say he expects a "simpler, state-based health care system" to replace Obamacare.

The Obama Administration's final antitrust fight

The FTC said Tuesday that it was suing Qualcomm, alleging that it unfairly uses its position as a dominant provider of a special type of processor, necessary for cellphone communications, to force its customers to pay higher licensing fees for technology patented by Qualcomm.

The suit was filed the day before one of two Democratic appointees to the FTC was set to leave the commission, suggesting the agency was keen to file the suit before it is staffed with Trump nominees. While Trump talked tough about merger enforcement during the campaign, he has staffed his transition team with antitrust experts who have a more traditional Republican attitude toward antitrust oversight.

What we're watching today:

The Bureau of Labor Statistics will release inflation stats at 8:30, with economists predicting that core prices rose by more than the Fed's 2% annual goal.

That means green lights for further interest rate increases, but the report should be an interesting insight into the recent burst of consumer confidence as well. Pantheon Macroeconomic's Ian Shepherdson points out that prices for cell phone service, higher education services, and airline tickets have all fallen substantially in recent months. He doesn't see that trend continuing, however, as the labor market tightens and oil prices climb.

Go deeper

Trump pushes to expand ban against anti-racism training to federal contractors

Trump speaking at Moon Township, Penns., on Sept. 22. Photo: Mandel Ngan/AFP via Getty Images

President Trump announced late Tuesday that the White House attempt to halt federal agencies' anti-racism training would be expanded to block federal contractors from "promoting radical ideologies that divide Americans by race or sex."

Why it matters: The executive order appears to give the government the ability to cancel contracts if anti-racist or diversity trainings focused on sexual identity or gender are organized. The memo applies to executive departments and agencies, the U.S. military, federal contractors and federal grant recipients.

Updated 2 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 9:30 p.m. ET: 31,467,508 — Total deaths: 967,881— Total recoveries: 21,583,915Map.
  2. U.S.: Total confirmed cases as of 9:30 p.m. ET: 6,890,662 — Total deaths: 200,710 — Total recoveries: 2,646,959 — Total tests: 96,612,436Map.
  3. Health: The U.S. reaches 200,000 coronavirus deaths — The CDC's crumbling reputation — America turns against coronavirus vaccine.
  4. Politics: Elected officials are failing us on much-needed stimulus.
  5. Business: Two-thirds of business leaders think pandemic will lead to permanent changes — Fed chair warns economy will feel the weight of expired stimulus.
  6. Sports: NFL fines maskless coaches.
Dan Primack, author of Pro Rata
3 hours ago - Economy & Business

GoodRx prices IPO at $33 per share, valued at $12.7 billion

Illustration: Sarah Grillo/Axios

GoodRx, a price comparison app for prescription drugs at local pharmacies, on Tuesday night raised $1.14 billion in its IPO, Axios has learned.

By the numbers: GoodRx priced its shares at $33 a piece, above its $24-$28 per share offering range, which will give it an initial market cap of around $12.7 billion.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!